Scientists generated recombinant SARS–CoV-2 harboring a catalytically inactive 2′-O-methyltransferase Nsp16, Nsp16mut, and analyzed viral replication in human lung epithelial cells.
[EMBO Reports]
Home Newsletters Immunology of Infectious Disease News Nsp16 Shields SARS–CoV-2 from Efficient MDA5 Sensing and IFIT1-Mediated Restriction
